Top Healthcare Market Research Panels in Turkey (2026 Edition)
Which of the healthcare market research panels in Turkey fits your brief? 7 providers scored on verification, data quality and compliance for 2026.
Quick answer
For large-scale, verified healthcare professional and patient data, Global Vox Populi provides the widest coverage; for specialized account-level and SKU-level intelligence in Turkey, BioNixus is effective; for comprehensive market tracking and local regulatory expertise, Ipsos and FA Research and Consultancy are strong options.
Securing reliable primary data in the Turkish healthcare sector requires balancing complex regulatory frameworks with the need for high-quality respondent pools. Marketing and insights teams must work through the specific demands of physician recruitment and patient data protection to make sure their commercial strategies are built on accurate evidence.
This assessment examines the top healthcare market research panels in Turkey, evaluating providers based on their ability to supply verified professional and patient insights. By comparing methodological rigor, compliance standards, and panel depth, this guide assists procurement and research leads in identifying the most suitable partner for their 2026 project requirements.
Top Healthcare Market Research Panels in Turkey: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | Global Vox Populi | Verified healthcare professional and patient panels | 90.0 |
| 2 | IQVIA Turkey | Clinical development and real-world evidence | 88.0 |
| 3 | Ipsos Turkey | Brand tracking and market understanding | 84.5 |
| 4 | FA Research and Consultancy | ISO-certified local medical market monitoring | 80.0 |
| 5 | BioNixus | Account-level and SKU-level brand data | 79.0 |
| 6 | Eksen | Multi-country B2B fieldwork in the Middle East and Africa | 71.0 |
| 7 | Panacea Market Research | Boutique pharmaceutical business intelligence | 69.5 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| Global Vox Populi | Physicians, patients, nurses, pharmacists, payers | Registration validation, identity fingerprinting, rolling re-validation | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 40,014 healthcare professionals; 27,917 nurses and allied health professionals; 638,081 patient profiles (in Turkey; Global Vox Populi panel records, Oct 2026) | Not published |
| IQVIA Turkey | Physicians, pharmacists, wholesalers, payers | Internal data validation and clinical registry cross-referencing | Not stated on pages reviewed | Project quote | Not published | Not published |
| Ipsos Turkey | Doctors, patients, general public | Proprietary panel authentication and quality checks | Not stated on pages reviewed | Project quote | Not published | Not published |
| FA Research and Consultancy | HCPs, patients, social groups | Panelist member validation and automated engagement checks | ISO 20252, ESOMAR | Project quote | Not published | Not published |
| BioNixus | Physicians, payers, hospital decision-makers | Identity and quality checks on every fieldwork wave | Not stated on pages reviewed | Project quote | Not published | Not published |
| Eksen | Nurses, physicians, payers, consumers | Proprietary panel management and fieldwork oversight | Not stated on pages reviewed | Project quote | Not published | Not published |
| Panacea Market Research | Physicians, medical representatives | Not published | Not stated on pages reviewed | Project quote | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| IQVIA Turkey | ● | ● | – | ● | – | ● |
| Ipsos Turkey | ● | ● | – | ● | – | ● |
| FA Research and Consultancy | ● | ● | ● | ● | ● | – |
| BioNixus | ● | – | – | ● | – | – |
| Eksen | ● | ● | – | ● | ● | – |
| Panacea Market Research | ● | – | – | ● | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Standardize your provider selection by evaluating each agency against seven core operational criteria that determine data reliability.
| Criterion | Weight | What it means here |
|---|---|---|
| Sample Quality and Verification | 25 | This criterion measures how providers recruit and maintain their panels, specifically focusing on the validation of medical credentials for physicians and pharmacists. In Turkey, high-quality providers must prove they source respondents through verified medical registries rather than open-access pools to make sure the data is representative of actual clinical practice. |
| Compliance, Certifications and Security | 20 | This evaluates adherence to ISO 20252, ISO 9001, and local data protection laws. Given the sensitivity of health data, providers in Turkey must demonstrate rigorous consent management and secure handling of patient information, alongside clear protocols for reporting adverse events in line with international pharmacovigilance standards. |
| Target Audience Reach | 15 | This assesses the depth and breadth of the provider's panels, particularly for hard-to-reach sub-specialties or specific patient groups. A strong provider in Turkey must demonstrate the ability to reach both private and public hospital staff, offering granular profiling that allows for precise targeting of niche therapeutic audiences. |
| Data Quality and Fraud Prevention | 10 | This measures the technical controls implemented to detect bots, duplicates, and speeders. For Turkish healthcare studies, effective providers use device fingerprinting and trap questions to maintain integrity, making sure that responses come from genuine, engaged healthcare professionals or patients rather than automated or non-relevant participants. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This evaluates the provider's capacity to offer a mix of qualitative and quantitative methods. Good providers in Turkey offer tools beyond standard surveys, such as in-depth interviews, mobile-optimized ethnography, and advanced analytical techniques like MaxDiff, supporting the diverse needs of commercial, medical affairs, and market access teams. |
| Client Service and Speed | 5 | This assesses the responsiveness and project management capabilities of the agency. In the fast-paced pharmaceutical industry, reliable partners provide transparent communication, rapid proposal turnarounds, and proactive problem-solving to make sure that fieldwork timelines are met without compromising the quality of the collected data. |
| Pricing and Feasibility Transparency | 5 | This measures the honesty of a provider regarding project feasibility and costing. A transparent partner provides upfront assessments of incidence rates and sample availability, making sure that researchers understand the realistic constraints of their study design before committing to a project in the Turkish market. |
Why these weights. In healthcare, a respondent who is not a verified professional or a genuine patient invalidates the study, so verification leads (25). Compliance follows at 20 because health data, HIPAA and adverse event reporting carry legal risk. Reach into specialties and conditions (15), fraud prevention and methods (10 each), service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: healthcare market research panels in Turkey
Global Vox Populi: best for verified healthcare professional and patient panels
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitGlobal Vox Populi is most suitable for complex, multi-stakeholder studies that require high-precision targeting of hard-to-reach clinical and patient groups in Turkey.
Global Vox Populi is an independent primary market research firm that maintains proprietary healthcare panels across 199 markets, including a significant presence in Turkey. The firm specializes in reaching highly specific audiences, from sub-specialist physicians to rare-disease patient groups, using verified data to inform commercial strategies.
Their operational model focuses on strict panel management and data integrity, offering researchers a reliable alternative to open-market samples. By using healthcare professionals and patient pools, the company supports complex studies that require high-precision targeting and rigorous compliance with international research standards.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in Turkey
40,014 panellists
- Primary & General15,894
- Internal Medicine Subspecialties3,538
- Acute, Peri-operative & Critical Care2,938
- Diagnostic & Laboratory2,914
- Surgical Specialties2,696
- Women's & Reproductive Health2,686
Nurses and allied health panel, in Turkey
27,917 panellists
- Registered Nurses8,629
- Advanced Practice Nurses528
- Licensed / Practical / Enrolled Nurses2,501
- Nursing Support (Aides / HCAs)1,040
- Midwives825
- Pharmacists & Pharmacy Techs2,326
Patient panel, in Turkey
638,081 patient profiles
- Aesthetics & Cosmetic211,429
- Cardiovascular45,975
- Women's Health32,876
- Dermatology32,549
- Ophthalmology31,299
- Endocrinology & Metabolic29,578
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in Turkey
1,035 panellists
- Provider: Access & Administrative Roles662
- Payer: Access & Coverage Roles373
Scorecard: 90.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 90.0 |
Core services
- Professional Panel Access: Access to physicians, nurses, and payers through proprietary, verified databases.
- Patient Data Collection: Direct recruitment of patients and caregivers across multiple therapeutic areas for longitudinal and ad-hoc studies.
- Advanced Methodology: Execution of complex research types using online survey platforms and qualitative techniques.
Strengths
- Verified Panel Depth: Total panel reach in Turkey includes 40,014 healthcare professionals and 638,081 patient profiles, with nurses and allied health experts numbering 27,917.
- Data Integrity Controls: Uses multi-layered validation including identity fingerprinting, geo-checks, and straight-lining detection to protect high-quality, fraud-free data collection.
- Regulatory Compliance: Maintains strict adherence to HIPAA and BHBIA guidelines for adverse event reporting and data privacy.
Innovation and technology
- Proprietary Platform: Surveys are programmed and hosted on a proprietary, secure platform, protecting full control over the respondent experience and data flow.
- Automated Validation: Rolling re-validation of clinical members against official registries makes sure that the professional panel remains accurate and up-to-date.
Impact on businesses
- Strategic Decision Support: Enables market access and brand teams to make evidence-based decisions regarding pricing, launch readiness, and patient adherence.
- Risk Mitigation: Provides reliable, verified data that reduces the commercial risk associated with launch and portfolio management in the Turkish market.
Why it may fit your brief
The provider fits briefs that demand rigorous verification and large, proprietary sample pools. For simple, ad-hoc consumer healthcare surveys where professional verification is less critical, other generalist providers may offer a more cost-effective alternative.
IQVIA Turkey: best for clinical development and real-world evidence
Strongest fitIQVIA is best for large pharmaceutical firms conducting clinical trials or seeking deep market access data in Turkey.
IQVIA Turkey offers a wide range of services for life sciences organizations, focusing on clinical trial optimization and real-world evidence generation. Their local teams work with pharmacy and wholesaler partners to address strategic challenges, including market access and patient adherence monitoring.
The firm uses proprietary data models and agentic AI platforms to help clients work through the Turkish healthcare system. Their approach connects clinical data with commercial intelligence, aiming to accelerate asset success and improve patient outcomes through informed decision-making.
Scorecard: 88.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 88.0 |
Core services
- Clinical Development: Full-service clinical trial solutions and site identification strategies tailored to the Turkish market.
- Real-World Evidence: Evidence generation to support market access and demonstrate the value of treatments.
- Commercial Intelligence: Strategic consulting for pharmaceutical, pharmacy, and wholesaler partners.
Strengths
- Proprietary Data Access: Uses petabytes of proprietary, non-identified patient records and global pharma sales data.
- Functional Support: Provides flexible outsourcing solutions to increase trial efficiency and quality.
- Technical Expertise: Integrates healthcare-grade AI and advanced analytics into clinical and commercial workflows.
Innovation and technology
- IQVIA.ai Platform: A unified agentic platform that connects data, technology, and analytics for faster decision-making.
- Predictive Clinical Development: Uses predictive modeling to optimize trial site identification and reduce risk.
Impact on businesses
- Asset Maximization: Helps pharmaceutical companies maximize the probability of success in competitive environments.
- Efficiency Gains: Reduces trial timelines and costs through improved data flow and process integration.
Why it may fit your brief
The provider fits complex clinical and commercial briefs requiring massive datasets. For smaller, ad-hoc qualitative studies, its scale may be less agile than boutique alternatives.
Ipsos Turkey: best for brand tracking and market understanding
Strongest fitIpsos is well-suited for brand managers and researchers looking for long-term tracking and public sentiment analysis in Turkey.
Ipsos Turkey provides a full range of market research services, including surveys, polls, and qualitative research for the healthcare sector. Their local team specializes in patient journey mapping and brand health tracking, using global standards to provide actionable insights for decision-makers.
By integrating data from diverse sources, including social media and surveys, the agency aims to help clients understand societal and market trends. Their healthcare service report is a key component of their offering, providing longitudinal data on healthcare system quality and public health issues.
Scorecard: 84.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 84.5 |
Core services
- Healthcare Research: Specialized surveys for doctors and patients to monitor healthcare perceptions.
- Brand Strategy: Brand health tracking and market strategy development for pharmaceutical brands.
- Qualitative Insights: Qualitative research services, including online communities and in-depth discussions.
Strengths
- Global Methodology: Applies proven global research frameworks to the specific context of the Turkish market.
- Diverse Data Integration: Uses data from surveys, social media, and polls to provide a holistic view.
- Expertise in Healthcare: Maintains long-term tracking of healthcare system quality and patient perceptions.
Innovation and technology
- AI-Driven Insights: Uses AI to analyze and deliver insights from various data sources.
- Ipsos Global Trends: Maintains large-scale tracking reports that provide macro-level context for healthcare research.
Impact on businesses
- Actionable Truth: Turns complex market data into clear, actionable truths for better decision-making.
- Strategic Alignment: Aligns local brand strategies with global healthcare trends and public sentiment.
Why it may fit your brief
The provider fits briefs that need global consistency and large-scale data. For highly specialized medical device technical research, smaller specialist firms might offer more focused KOL access.
FA Research and Consultancy: best for ISO-certified local medical market monitoring
Strongest fitFA Research is suitable for local and international pharma teams needing an ISO-compliant local partner in Turkey.
FA Research and Consultancy provides quantitative and qualitative healthcare research, operating extensively within the Turkish medical market. They adhere to international quality standards, including ISO 20252 and ESOMAR codes, to protect reliability in their data collection and project management.
Through their Ankethink panel, they offer an automated platform for reaching target healthcare audiences. The firm monitors medical market developments and regulatory shifts in Turkey closely, providing clients with guidance on research design and feasibility in a complex, changing environment.
Scorecard: 80.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | faresearch.com.tr (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | faresearch.com.tr (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | faresearch.com.tr (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | faresearch.com.tr (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | faresearch.com.tr (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | faresearch.com.tr (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | faresearch.com.tr (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 80.0 |
Core services
- Panel Research: Access to the Ankethink web-based platform for reaching healthcare professionals.
- Fieldwork Services: Quantitative and qualitative data collection with expert project management.
- Research Consultancy: Guidance on research design, sample framing, and data processing.
Strengths
- Quality Certification: Maintains ISO 20252 and Turkish Researchers Association Trustworthy Research certification.
- Local Market Knowledge: Tracks bureaucracy and medical market developments closely to guide project design.
- Platform Automation: Ankethink provides automated recruitment, engagement, and incentive management.
Innovation and technology
- Ankethink Platform: An end-to-end panel management application that optimizes respondent engagement and validation.
- Technical Excellence: Focuses on technical accuracy and on-time delivery despite local regulatory or bureaucratic obstacles.
Impact on businesses
- Reliable Outputs: Protects high-quality data delivery through rigorous adherence to international standards.
- Cost Optimization: Helps clients save costs through proactive guidance on research design and feasibility.
Why it may fit your brief
The provider is a strong choice for projects requiring strict quality certifications. For projects needing deep, pre-existing international panels in obscure markets, global agencies might offer more immediate access.
BioNixus: best for account-level and SKU-level brand data
Strongest fitBioNixus is best for commercial teams needing granular competitor data to drive specific brand launches.
BioNixus is a global primary market research firm that delivers granular brand versus competitor data in 48 countries. They bridge the gap left by syndicated data feeds by providing primary research that focuses on sub-accounts, traditional trade, and SKU-level performance.
Their healthcare division is deeply integrated with their broader industry research, offering statistically solid physician and payer surveys. The firm supports commercial and medical affairs teams with evidence on market sizing, pricing, and competitive environments, designed for immediate use by marketing leads.
Scorecard: 79.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.0 |
Core services
- Account-Level Research: Primary research to uncover SKU-level performance at named hospital and retail accounts.
- Quantitative Physician Surveys: Statistically solid physician and payer surveys using conjoint and MaxDiff methodologies.
- Strategic Consulting: Consulting on market sizing, pricing, reimbursement, and launch readiness.
Strengths
- Granular Data: Provides breakdowns that syndicated feeds often miss, such as traditional trade and sub-regions.
- Fast Turnaround: Capable of delivering proposals within 48 hours to meet urgent commercial needs.
- Decision-Ready Outputs: Produces decision packs tailored for commercial directors rather than raw data exports.
Innovation and technology
- Custom Research Design: Designs instruments around how decisions are made rather than using template decks.
- Multi-Phase Programs: Integrates quantitative and qualitative tracking to inform complex crisis management or launch roadmaps.
Impact on businesses
- Commercial Planning: Directly informs share plans and launch campaigns with actionable, account-level evidence.
- Market Access: Provides HTA dossiers and payer intelligence to support pricing and reimbursement strategies.
Why it may fit your brief
The provider is excellent for tactical commercial questions. For broad, longitudinal public health tracking, other generalist firms with larger public opinion panels might be a better choice.
Eksen: best for multi-country B2B fieldwork in the Middle East and Africa
Strongest fitEksen fits companies that need reliable fieldwork across Turkey and neighboring regional markets.
Eksen provides comprehensive fieldwork solutions, with a strong focus on the Turkish healthcare sector. They manage their own healthcare panels, covering diverse stakeholders from nurses to national-level payers, and support clients with insights into disease awareness and patient journeys.
With offices across several key regional cities, the firm specializes in reaching senior decision-makers in B2B contexts. Their approach combines local fieldwork expertise with a broad geographic reach, enabling them to execute complex, multi-country projects for commercial and clinical clients.
Scorecard: 71.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | eksenresearch.com (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 71.0 |
Core services
- Fieldwork Solutions: Comprehensive qualitative and quantitative data collection services.
- B2B Research: Specialized B2B research reaching senior stakeholders and decision-makers.
- Sensory Research: Professional sensory evaluation through their dedicated subsidiary company.
Strengths
- Regional Reach: Operations across Turkey, Middle East, and Africa provide strong regional coordination.
- Stakeholder Access: Expertise in engaging hard-to-reach senior decision-makers and healthcare professionals.
- Independent Operation: Provides flexible, independent fieldwork services tailored to specific client needs.
Innovation and technology
- Sensumer: A dedicated sensory evaluation platform for scientifically-backed consumer insights.
- Regional Networks: Strategically located offices allow for localized project management in key growth markets.
Impact on businesses
- Competitive Advantage: Helps brands stay in tune with shifting consumer and professional expectations.
- Commercial Confidence: Provides insights that support product launches and brand refreshes.
Why it may fit your brief
The provider is a strong partner for regional fieldwork coordination. For studies requiring specific, highly regulated medical sub-specialty panels, firms with more extensive medical registry partnerships might be better suited.
Panacea Market Research: best for boutique pharmaceutical business intelligence
Strongest fitPanacea fits mid-sized or local pharma firms needing personalized, high-touch research support.
Panacea Market Research focuses on supporting pharmaceutical companies with strategic intelligence and research services. Founded in 2017, the firm provides data collection and field management, using a boutique approach to address the specific business challenges of their clients.
Their services cover both quantitative and qualitative research, with a focus on brand performance, sales team effectiveness, and communication evaluation. The team combines years of industry experience to offer consultancy alongside their research operations.
Scorecard: 69.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Sample Quality and Verification | 25 | 7/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Data Quality and Fraud Prevention | 10 | 7/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | panacea.com.tr (2 pages reviewed), Oct 2026 |
| Weighted score | 100 | 69.5 |
Core services
- Market Intelligence: Strategic business intelligence and consultancy for pharmaceutical clients.
- Quantitative Research: Data collection for brand tracking and sales performance analysis.
- Communication Research: Evaluation of sales team performance and communication channel effectiveness.
Strengths
- Boutique Approach: Provides personalized service and deep industry experience to every client engagement.
- Strategic Focus: Combines research findings with consultancy to offer deeper business impact.
- Sector Specialization: Deep expertise specifically in the healthcare and pharmaceutical sector.
Innovation and technology
- Strategic Intelligence: Focuses on solving complex problems through a blend of research and consultancy.
- Performance Tracking: Specialized methodologies for tracking the effectiveness of medical representative visits.
Impact on businesses
- Sales Excellence: Helps sales teams improve their performance through clear feedback and performance tracking.
- Brand Excellence: Supports pharmaceutical brands in achieving business excellence through strategic insights.
Why it may fit your brief
The provider is well-suited for specialized sales and brand intelligence. For massive, multi-country quantitative data projects, firms with larger proprietary panels might be more efficient.
How HCP and patient verification actually works in Turkey
Protect data integrity by demanding documentation of the provider's professional verification and identity-check protocols.
Verify Professional Credentials
For physician and pharmacist research, you must insist on proof that the provider validates respondents against official Turkish medical registries. A reputable firm performs manual or automated checks of medical license numbers at the point of recruitment and during ongoing panel maintenance. If a provider cannot confirm how they identify a licensed physician versus a non-professional, the risk of data contamination is high. Always ask to see their process for handling license renewals and inactive practitioners, as these can quickly degrade the quality of your professional data pool.
Implement Multi-Factor Identity Checks
Beyond credentials, use providers that use device fingerprinting and IP address geolocation to confirm the respondent is physically located in Turkey. Fraudulent actors often use VPNs to mimic local traffic, so a solid verification process must flag suspicious connection patterns. Ask for evidence of how the provider cross-references respondent identity with unique device IDs to prevent the same individual from participating in your study multiple times under different aliases. This is essential for protecting the validity of your quantitative results, especially for high-value physician research.
Audit Consent and Privacy Procedures
Healthcare data in Turkey is subject to strict privacy regulations. Protect your partner maintains a double opt-in process where panelists verify their email or phone number before they are allowed to join a study. Request a summary of their privacy policy, specifically how they manage granular consent for health-related questions. A compliant provider will provide clear evidence of how they protect sensitive information and meet local data protection requirements, which is a mandatory step for any pharmaceutical research project involving patient or professional health data.
Monitor Completion Quality
Quality control should continue during the fieldwork phase. Ask the provider to report on their completion-quality scoring, which flags respondents who complete surveys too quickly or provide inconsistent answers across similar questions. This monitoring makes sure that even if a respondent is a verified professional, their specific survey contribution remains high-quality. Providers should automatically exclude respondents who fail these trap questions before delivering the final dataset. If a provider is hesitant to explain their logic for removing fraudulent completes, it is a sign that their data quality protocols may be insufficient.
How to choose the right provider in Turkey
Select a partner based on their specific alignment with your project's regulatory and methodological needs.
- Define Research Objective: Determine if your study requires broad market tracking or deep, niche clinical insights. Select a provider that has a proven track record in the specific therapeutic area you are investigating.
- Check Regulatory Compliance: Confirm that the provider adheres to ISO 20252 and understands the specific pharmacovigilance requirements in Turkey. This is essential for projects involving adverse event reporting.
- Assess Panel Methodology: Ask for the provider's panel recruitment sources and verification frequency. Prioritize those who use proprietary, verified pools over those who rely on open-internet recruitment.
- Evaluate Technical Capability: Make sure the agency can manage the specific quantitative or qualitative methods your study requires, such as conjoint analysis or mobile ethnography. Test their platform's usability for your target audience.
- Review Project Management: Discuss communication protocols and contingency plans for fieldwork obstacles. A good partner should be transparent about feasibility and proactive in solving recruitment challenges.
Questions to ask before you commission
- How often do you re-verify the medical licenses of the physicians in your Turkish panel?
- What specific steps do you take to identify and remove bots and fraudulent respondents during fieldwork?
- Can you provide your process for reporting adverse events according to BHBIA or local pharmacovigilance guidelines?
- How do you handle recruitment for low-incidence patient groups that are not easily found in public registries?
- What is your average response rate for your physician panel in Turkey over the last six months?
- How does your internal data quality score impact the final dataset you deliver to the client?
Common pitfalls to avoid
- Over-reliance on Open Samples: Using open-internet panels for physician research often leads to low-quality data and professional misidentification.
- Ignoring Local Regulations: Failing to account for the Turkish reimbursement environment and TİTCK requirements can lead to unusable data for market access.
- Poor Verification Documentation: Not demanding proof of license validation early in the process creates significant risk for your commercial strategy.
- Lack of Pilot Testing: Skipping a small pilot phase can result in poorly designed survey instruments that clinicians are unable or unwilling to complete.
What a feasibility check should include
Validate project feasibility early by requesting a detailed assessment of respondent availability and incidence rates.
Target Audience Availability
Request a count of your specific target audience in Turkey, broken down by specialty or patient condition. This prevents delays when the actual incidence rate is lower than initially estimated.
Incidence Rate Estimation
Ask for a realistic estimate of the incidence rate for your target profile, as this is the most common reason for budget and timeline overruns. A partner should provide this based on historical data.
Timeline Realism
Protect the provider accounts for local holidays, medical congresses, and physician availability. A feasible timeline must include buffer time for recruitment in busy clinical settings.
Incentive Strategy
Discuss the appropriate incentive levels for your target audience, as physicians in Turkey require fair-market compensation to protect high engagement and completion quality.
Conclusion
Choosing the right partner for your research requires balancing the need for deep, verified professional access with the ability to work through local regulatory requirements. For large-scale studies requiring high-precision targeting and rigorous compliance, Global Vox Populi provides the most comprehensive verified panel access. If your focus is primarily on granular account-level commercial intelligence, firms like BioNixus offer specialized tactical support.
Use the scorecard provided in this assessment to match your project’s specific needs with the strengths of each provider. Prioritize partners who can demonstrate clear verification protocols and a deep understanding of the Turkish healthcare market. By focusing on data quality and regulatory alignment, you will make sure that your research produces the actionable evidence required for successful commercial and clinical decision-making in 2026.
Planning research in Turkey? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
How do I select a healthcare market research partner in Turkey?
Select a partner based on their ability to prove respondent verification, their adherence to international quality standards like ISO 20252, and their depth in your specific therapeutic area. Prioritize agencies that own their panels and can demonstrate a clear, transparent process for validating medical credentials and patient profiles.
What are the regulatory requirements for healthcare market research in Turkey?
Healthcare research in Turkey is governed by local data protection laws, which mandate strict consent management and secure handling of personal health information. Additionally, studies involving pharmaceutical products must comply with pharmacovigilance guidelines, including the mandatory reporting of adverse events to the relevant authorities and the client.
Do healthcare market research panels in Turkey include public hospital physicians?
Yes, high-quality panels include physicians from both public and private hospitals. However, public hospital physicians are often more difficult to reach due to high workload and regulatory constraints. A good provider will have established methods for reaching these professionals, often through professional associations or specific recruitment channels.
How does the SGK reimbursement system impact market research in Turkey?
The SGK reimbursement system is a central component of the Turkish healthcare market. Market research often focuses on understanding how this system influences physician prescribing habits, patient access to treatments, and the willingness of stakeholders to adopt new therapies. Research designs must often account for these economic factors.
Are there specialized healthcare market research firms for TİTCK-aligned studies?
Yes, several firms in Turkey specialize in research that aligns with TİTCK regulations. These agencies have deep knowledge of the regulatory environment and can guide clients on the necessary documentation and ethical requirements for conducting studies that involve pharmaceutical products or medical devices.
What is the difference between global and local healthcare research providers in Turkey?
Global providers bring international research methodologies, standardized quality controls, and large-scale panels, while local providers offer deep regional expertise, knowledge of local bureaucracy, and more personalized project management. The best choice depends on whether your project requires global consistency or deep local, context-specific insights.
Why is medical license verification critical for healthcare panels?
Medical license verification is critical because it makes sure that the data collected actually comes from qualified healthcare professionals. Without this, there is a significant risk that your research will be based on responses from non-relevant individuals, which can severely compromise the accuracy and reliability of your commercial insights.
How do I make sure my patient research is compliant with privacy laws?
Protect compliance by using providers who implement double opt-in consent and clear data handling procedures. Your research design should minimize the collection of unnecessary personal data, and all patient information must be stored and processed in accordance with local data protection laws and international standards like HIPAA or GDPR.